Printer Friendly
The Free Library
19,573,962 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ADAC introduces MCD Technology in Europe.


MILPITAS, Calif.--(HealthWire)--Sept. 12, 1995--ADAC Laboratories (ADAC ADAC Allgemeiner Deutscher Automobil Club (German automobile club)
ADAC Aboriginal Drug and Alcohol Council
ADAC Art Directors and Artists Club (Sacramento, California)
ADAC Alcohol and Drug Abuse Council
:NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
) introduced molecular coincidence detection (MCD) to the European market at the European Association of Nuclear Medicine (EANM) in Brussels, Belgium.

Coincidence imaging protocols, previously limited to costly dedicated PET (Positron Emission Tomography positron emission tomography: see PET scan.
positron emission tomography (PET)

Imaging technique used in diagnosis and biomedical research.
) imaging systems, provide valuable diagnostic information for a number of oncologic, cardiac and neurologic conditions. MCD adds this coincidence capability to ADAC's VERTEX EPIC(TM) and SOLUS Solus® Cardiology An ASIR, single-chamber, rate-modulated pulse generator. See Pacemaker.  EPIC(TM) nuclear medicine imaging nuclear medicine imaging,
n the diagnostic imaging field that evaluates organ function by injecting isotopes into a structure and documenting the amount of radiation emanating from the tissues.
 systems.

The capability to combine PET and SPECT SPECT single-photon emission computed tomography.

SPECT
abbr.
single photon emission computed tomography


SPECT,
n See single photon emission computer tomography.
 (Single Photon Emission Computed Tomography single photon emission computed tomography
n. Abbr. SPECT
Tomographic imaging of local metabolic and physiological functions in tissues.
) imaging on a single dual function system offers healthcare providers the opportunity of both meeting the demands for improved diagnostic imaging and decreasing the overall cost of patient care.

Andy Eckert, President of ADAC Medical Systems stated, "Customer reaction to MCD at the EANM meeting was exceptional, with capacity attendance at two special seminars dedicated to the introduction." At the concluding highlights lecture of the EANM meeting, Prof. Dr. Frans Corstens from Nijmegen University in Holland discussed the most significant innovations in imaging and instrumentation. As Prof.

Dr. Corstens concluded the meeting by displaying ADAC's MCD images and explaining the potential of this new technology, he stated, "This new development represents a potential boon to nuclear medicine."

Mr. Eckert further stated, "ADAC expects to complete multi center MCD clinical trials next year. These trials are expected to demonstrate MCD's clinical efficacy and excellent imaging quality as compared to conventional imaging techniques for certain applications. MCD is believed to be a major step forward in meeting clinical demand for PET imaging diagnostic quality at significant cost savings.

"Assuming satisfactory demonstration of both quality and value, we expect rapid user acceptance of this new technology. Current customers seem to be more attracted to our existing dual head cameras on the basis of MCD's design, which incorporates a simple field upgrade path."

ADAC Laboratories is recognized as the world market share leader in nuclear medicine and a leading supplier of radiology and laboratory information systems in North America. For the second consecutive year, ADAC has been selected to receive a site visit for the prestigious Malcolm Baldrige National Quality Award The Malcolm Baldrige National Quality Award is given by the United States National Institute of Standards and Technology. Through the actions of the National Productivity Advisory Committee chaired by Jack Grayson, it was established by the Malcolm Baldrige National Quality . The company headquarters are in Milpitas, California.

CONTACT: ADAC Laboratories

Kathleen Call, 408/321-9100 x2665
COPYRIGHT 1995 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1995, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 12, 1995
Words:368
Previous Article:North American Trust, Inc. Special Meeting of Stockholders Approves Sale of Substantially All Assets and Plan of Dissolution and Liquidation.
Next Article:Hunt Manufacturing Co. announces acquisition of product line.
Topics:



Related Articles
ADAC awarded "Image of the Year" for MCD breakthrough at Society of Nuclear Medicine Meeting.
ADAC Announces Third Quarter Results.
ADAC Receives FDA Approval for Molecular Coincidence Detection.
ADAC Announces Joint Program with P.E.T.Net to Advance New Cancer Detection Modality; ADAC Molecular Coincidence Detection Represents a Breakthrough...
ADAC Receives Marketing Approvals in Japan; ADAC's Market Opportunities Expand in Nuclear Medicine's Third Largest Market.
ADAC Announces Record Third Quarter Results; 25 Percent Increase in Q3 Earnings Per Share, Excluding One-Time Charge.
ADAC Receives FDA 510k Clearance to Market MCD/ACTM.
Beijing Medical University Orders China's First Molecular Coincidence Camera From ADAC.
Beijing Medical University Orders China's First Molecular Coincidence Camera From ADAC.
ADAC Laboratories Announces Record Bookings of C-PET Positron Emission Tomography Scanners in Fiscal Q1 2000.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles